N-desmethylrosiglitazone

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2015
01220032015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
PURPOSE To evaluate the potential effects of vorapaxar on the pharmacokinetics and safety of rosiglitazone. METHODS This was an… (More)
Is this relevant?
2012
2012
AIMS To determine the effect of febuxostat on cytochrome P450 2C8 (CYP2C8) activity using rosiglitazone as a CYP2C8 substrate… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2007
2007
AIMS To investigate the effect of multiple dosing with montelukast, a selective leukotriene-receptor antagonist, on the… (More)
Is this relevant?
2006
2006
AIMS To determine the effect of CYP2C8 genotype and of fluvoxamine on the pharmacokinetics of rosiglitazone. METHODS Twenty… (More)
Is this relevant?
2005
2005
Previous in vitro studies have demonstrated that quercetin inhibits CYP2C8, but there are no available data to indicate that… (More)
Is this relevant?
2005
2005
AIMS Rosiglitazone, a thiazolidinedione antidiabetic medication used in the treatment of Type 2 diabetes mellitus, is… (More)
Is this relevant?
2003
2003
Our aim was to investigate possible interaction between gemfibrozil and rosiglitazone, a thiazolidinedione antidiabetic drug. In… (More)
  • table 1
  • figure 1
Is this relevant?